Inactive Instrument

Granules India Ltd. Stock NSE India S.E.

Equities

INE101D01012

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Granules India Ltd.
Sales 2024 45.06B 540M Sales 2025 * 51.28B 615M Capitalization 101B 1.22B
Net income 2024 4.05B 48.59M Net income 2025 * 5.84B 70.06M EV / Sales 2024 2.31 x
Net Debt 2024 * 8.13B 97.42M Net Debt 2025 * 7.96B 95.48M EV / Sales 2025 * 2.13 x
P/E ratio 2024
25.7 x
P/E ratio 2025 *
17.6 x
Employees -
Yield 2024 *
0.33%
Yield 2025 *
0.33%
Free-Float 53.27%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 60 22-01-04
Chief Executive Officer 69 91-03-17
Director of Finance/CFO 44 22-12-29
Members of the board TitleAgeSince
Director/Board Member 70 13-02-18
Director/Board Member 62 21-12-12
Director/Board Member 67 Feb. 19
More insiders
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
More about the company